Literature DB >> 8090061

Cholesterol secretion from hepatocytes induced by triacylglycerol and apolipoprotein E.

S H Quarfordt1, B A Landis, M O Farouk, B S Oswald.   

Abstract

The mechanism for the increase in plasma cholesterol levels in cholesterol-fed rats following chylomicron transport was investigated in intact animals, in isolated perfused liver, and in hepatocytes in monolayer cultures. Intravenous administration of egg phosphatidylcholine in amounts greater than those required to cause a plasma cholesterol response when given as chylomicrons was without effect. This makes it unlikely that increased plasma cholesterol levels resulted from the recruitment of tissue cholesterol by the plasma chylomicron phospholipids that persisted in the plasma after triacylglycerol clearance. The hepatic origin of the increased plasma cholesterol levels was directly confirmed by two hepatic perfusion experiments. When cholesterol-fed rats received intravenous chylomicrons prior to isolated hepatic perfusion, more cholesterol was secreted by the liver than when the rats were injected intravenously with buffer. Perfusion of apolipoprotein E (apo E)-rich triacylglycerol emulsions through the livers also enhanced cholesterol secretion. The increase in hepatocyte cholesterol secretion seen with cholesterol-fed rats was also noted in monolayer cultures following incubation with apo E rich-triacylglycerol emulsions. The apolipoprotein or the emulsion alone, or apo E-rich phosphatidylcholine liposomes, had no effect. The data confirm previous indirect observations that the liver is the source of cholesterol that appears in plasma following transport of chylomicrons or following a lipid-rich meal in cholesterol-fed rats. The data also re-emphasize the importance of providing apo E with triacylglycerol emulsions to initiate secretion of lower density lipoproteins by the liver.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090061     DOI: 10.1007/bf02537309

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  21 in total

1.  Molecular complexes in the isolation and characterization of plasma lipoproteins.

Authors:  D G CORNWELL; F A KRUGER
Journal:  J Lipid Res       Date:  1961-04       Impact factor: 5.922

2.  Receptor-mediated control of cholesterol metabolism.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1976-01-16       Impact factor: 47.728

3.  A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.

Authors:  L L ABEL; B B LEVY; B B BRODIE; F E KENDALL
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

4.  Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.

Authors:  F Shelburne; J Hanks; W Meyers; S Quarfordt
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

5.  Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity.

Authors:  A Scanu; J Toth; C Edelstein; S Koga; E Stiller
Journal:  Biochemistry       Date:  1969-08       Impact factor: 3.162

6.  Rat plasma cholesterol after particulate triacylglycerol clearance.

Authors:  S H Quarfordt; B S Oswald; B A Landis; E DeFaria; Y Yamaguchi
Journal:  Biochim Biophys Acta       Date:  1991-04-03

7.  Effect of apoE on triglyceride emulsion interaction with hepatocyte and hepatoma G2 cells.

Authors:  B Oswald; S Quarfordt
Journal:  J Lipid Res       Date:  1987-07       Impact factor: 5.922

8.  Interaction of aging and dietary fat in the regulation of low density lipoprotein transport in the hamster.

Authors:  D K Spady; J M Dietschy
Journal:  J Lipid Res       Date:  1989-04       Impact factor: 5.922

9.  Alterations of rat hepatic cholesterogenesis by heterologous lipoproteins.

Authors:  L Jakoi; S H Quarfordt
Journal:  J Biol Chem       Date:  1977-10-10       Impact factor: 5.157

10.  The interaction of heparin with an apoprotein of human very low density lipoprotein.

Authors:  F A Shelburne; S H Quarfordt
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.